Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts

American Journal of Physiology - Cell Physiology

Volumn 286, Issue 2 55-2, 2004, Pages

  Short, Megan ^a   Nemenoff, Raphel A ^a   Zawada, W Michael ^a   Stenmark, Kurt R ^a   Das, Mita ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Bromodeoxyuridine incorporation; c Jun NH2 terminal kinase; Extracellular regulated kinase; G q; G i; Transforming growth factor 1; smooth muscle actin promoter activity

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA SMOOTH MUSCLE PROTEIN; BROXURIDINE; G ALPHA12 PROTEIN; G ALPHA16 PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; PROTEIN; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ADVENTITIA; ALPHA SMOOTH MUSCLE ACTIN GENE; ANIMAL CELL; ARTICLE; CATTLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA SYNTHESIS; FIBROBLAST; FIBROSIS; GENE; GENE ACTIVATION; GENE EXPRESSION; HYPOXIA; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PULMONARY ARTERY; SIGNAL TRANSDUCTION;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0742270734     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00169.2003     Document Type: Article

References (48)

1. Alfranca A, Gutierrez MD, Vara A, Aragones J, Fidal F, and Landazuri MO. c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol Cell Biol 22: 12-22, 2002.
2. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, and Anderson DW. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98: 13681-13686, 2001.
3. Bogatkevich GS, Tourkina E, Silver RM, and Ludwicka-Bradley A. Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J Biol Chem 276: 45184-45192, 2001.
4. Boyer AS, Erickson CP, and Runyan RB. Epithelial-mesenchymal transformation in the embryonic heart is mediated through distinct pertussis toxin-sensitive and TGF-β signal transduction mechanisms. Dev Dyn 214: 81-91, 1999.
5. Das M, Bouchey D, Moore M, Nemenoff RA, and Stenmark KR. Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on G-protein-mediated activation of mitogen-activated protein kinases. J Biol Chem 276: 15631-15640, 2001.
6. Das M, Dempsey EC, Bouchey D, Reyland MR, and Stenmark KR. Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: potential contribution of specific protein kinase C isozymes. Am J Respir Cell Mol Biol 22: 15-25, 2000.
7. Das M, Dempsey EC, Reeves JT, and Stenmark KR. Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia. Am J Physiol Lung Cell Mol Physiol 282: L976-L986, 2002.
8. Davis RJ. MAPKs: new JNK expands the group. Trends Biochem Sci 19: 470-473, 1994.
9. Desmouliere A and Gabbiani G. The Vascular Smooth Muscle Cell, edited by Schwartz S, and Mecham R. New York: Academic, 1995, p. 329-359.
10. Dhanasekaran N and Prasad MV. G protein subunits and cell proliferation. Biol Signals Recept 7: 109-117, 1998.
11. Dunn C, Wiltshire C, MacLaren A, and Gillespie AF. Molecular mechanism and biological functions of c-Jun N-terminal kinase signaling via the c-Jun transcription factor. Cell Signal 14: 585-593, 2002.
12. Ellenrieder V, Hendler SF, Boeck W, Seufferlein T, Menke A, Ruhland C, Adler G, and Gress TM. Transforming growth factor β1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 61: 4222-4228, 2001.
13. Falanga V, Qian SW, Danielpour D, Katz MH, Roberts AB, and Sporn MB. Hypoxia upregulates the synthesis of TGFβ1 by human dermal fibroblasts. J Invest Dermatol 97: 634-637, 1991.
14. Feldkamp MM, Lau N, Rak J, Kerbel RS, and Guha A. Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int J Cancer 81: 118-124, 1999.
15. Fine LG, Orphanides C, and Norman JT. Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int 53, Suppl 65: S74-S78, 1998.
16. Fuchs SY, Adler V, Pincus MR, and Ronai Z. MEKK1/JNK signaling stabilizes and activates p53. Proc Natl Acad Sci USA 95: 10541-10546, 1998.
17. Guha Roy S, Nozaki Y, and Phan SH. Regulation of α-smooth muscle actin gene expression in myofibroblast differentiation from rat lung fibroblasts. Int J Biochem Cell Biol 33: 723-734, 2001.
18. Gupta S, Campbell D, Derijard B, and Davis RJ. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267: 389-393, 1995.
19. 2-terminal kinase-dependent pathway. Am J Respir Crit Care Med 163: 152-157, 2001.
20. 2-terminal kinase-dependent pathway. J Allergy Clin Immunol 107: 1001-1008, 2001.
21. 2-terminal kinase-dependent pathway. J Biol Chem 272: 25845-25850, 1997.
22. Ishikawa Y and Kitamura M. Unexpected suppression of alpha-smooth muscle actin, the activation marker of mesangial cells, by pp60v-src tyrosine kinase. Biochem Biophys Res Commun 244: 806-811, 1998.
23. Kobayashi S, Conforti L, Zhu WH, Beitner-Johnson D, and Millhorn DE. Role of the D2 dopamine receptor in molecular adaptation to chronic hypoxia in PC12 cells. Pflügers Arch 438: 750-759, 1999.
24. Lowndes JM, Gupta SK, Osawa S, and Johnson GL. GTPase-deficient Gαi2 oncogene gip2 inhibits adenylylcyclase and attenuates receptor-stimulated phospholipase A2 activity. J Biol Chem 266: 14193-14197, 1991.
25. Mara F. Chemokines in liver inflammation and fibrosis. Front Biosci 7: 1899-1914, 2002.
26. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276: 75-81, 1997.
27. Mecham RP, Whitehouse LA, Wrenn DS, Parks WC, Griffin GL, Senior RM, Crouch CE, Stenmark KR, and Voelkel NF. Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science 25: 423-426, 1987.
28. Min B, Foster DN, and Strauch AR. The 5′-flanking region of the mouse vascular smooth muscle α-actin gene contains evolutionarily conserved sequence motifs within a functional promoter. J Biol Chem 265: 16667-16675, 1990.
29. 2+ channels in inspiratory brainstem neurones: intracellular signalling pathways and metabotropic glutamate receptors. Brain Res 853: 60-67, 2000.
30. Nemenoff RA. Vasopressin signaling pathways in vascular smooth muscle cells. Front Biosci 3: 194-207, 1998.
31. o are target proteins of reactive oxygen species. Nature 408: 492-495, 2000.
32. Norman JT, Clark IM, and Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 58: 2351-2366, 2000.
33. Pache JC, Christakos PG, Gannon DE, Mitchell JJ, Low RB, and Leslie KO. Myofibroblasts in diffuse alveolar damage of the lung. Mol Pathol 11: 1064-1070, 1998.
34. Pugh CW. Oxygen and genes in health and disease. QJM 90: 307-310, 1997.
35. Qian NX, Russell M, Buhl AM, and Johnson GL. Expression of GTPase-deficient Gα16 inhibits swiss 3T3 cell growth. J Biol Chem 269: 17417-17423, 1994.
36. Sartore S, Chiavegato A, Faggin E, Franch R, Puato M, Ausoni S, and Pauletto P. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling. Circ Res 89: 1111-1121, 2001.
37. Semenza GL. Hypoxia-inducible factor-1 and the molecular physiology of oxygen homeostasis. J Lab Clin Med 131: 207-214, 1998.
38. Stenmark KR, Gerasimovskaya E, Nemenoff RA, and Das M. Hypoxic activation of adventitial fibroblasts: role in vascular remodeling. Chest 122: 326-334, 2002.
39. Stenmark KR and Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 59: 89-144, 1997.
40. Van Biesen T, Luttrell LM, Hawes BE, and Lefkowitz RJ. Mitogenic signaling via G protein-coupled receptors. Endocr Rev 17: 698-714, 1996.
41. Van Putten V, Li X, Maselli J, and Nemenoff RA. Regulation of smooth muscle α-actin promoter by vasopressin and platelet-derived growth factor in rat aortic vascular smooth muscle cells. Circ Res 75: 1126-1130, 1994.
42. Vaugham MB, Howard EW, and Tomasek JJ. Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 257: 180-189, 2000.
43. Vyalov SL, Gabbiani G, and Kapanci Y. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol 143: 1754-1765, 1993.
44. Wainwright LJ, Lasorella A, and Iavarone A. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc Natl Acad Sci USA 98: 9396-9400, 2001.
45. Wang J, Seth A, and McCulloch CAG. Force regulates smooth muscle actin in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 279: H2776-H2785, 2000.
46. Whitmarsh AJ, Yang SH, Su MS, Sharrocks AD, and Davis RJ. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol 17: 2360-2371, 1997.
47. Yun Z, Maecker HL, Johnson RS, and Giaccia AJ. Inhibition of PPARγ2 gene expression by the HIF-1-regulated gene DEC1/Stra 13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2: 331-341, 2002.
48. Zhang K and Phan SH. Cytokines and pulmonary fibrosis. Biol Signals 5: 232-239, 1996.